dalteparin has been researched along with Coronary Restenosis in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Various clinical studies in unstable angina and acute coronary syndrome have proved that clivarine in a dosage of 3436anti-Xa units twice daily is an effective antithrombotic agent." | 2.42 | Reviparin sodium clivarine: a review of its therapeutic use. ( Gore, M; Kelkar, P; Rege, N; Ross, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, SG | 1 |
| Katritsis, DG | 1 |
| Korovesis, S | 1 |
| Tzanalaridou, E | 1 |
| Giazitzoglou, E | 1 |
| Zografos, T | 1 |
| Meier, B | 1 |
| Bosanquet, N | 1 |
| Jönsson, B | 1 |
| Fox, KA | 1 |
| Day, JR | 1 |
| Malik, IS | 1 |
| Weerasinghe, A | 1 |
| Poullis, M | 1 |
| Nadra, I | 1 |
| Haskard, DO | 1 |
| Taylor, KM | 1 |
| Landis, RC | 1 |
| Chisholm, RJ | 1 |
| Cantor, W | 1 |
| Gore, M | 1 |
| Kelkar, P | 1 |
| Rege, N | 1 |
| Ross, C | 1 |
| Grassman, ED | 1 |
| Leya, F | 1 |
| Fareed, J | 1 |
| Lewis, BE | 1 |
| Bacher, P | 1 |
| Loeb, HS | 1 |
| Moran, JF | 1 |
| Dangas, G | 1 |
| Iakovou, I | 1 |
| Hong, YJ | 1 |
| Jeong, MH | 1 |
| Lee, SH | 1 |
| Park, OY | 1 |
| Kim, JH | 1 |
| Kim, W | 1 |
| Rhew, JY | 1 |
| Ahn, YK | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Suh, SP | 1 |
| Ahn, BH | 1 |
| Kim, SH | 1 |
| Kang, JC | 1 |
2 reviews available for dalteparin and Coronary Restenosis
| Article | Year |
|---|---|
Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary | 2003 |
Reviparin sodium clivarine: a review of its therapeutic use.
Topics: Anticoagulants; Coronary Disease; Coronary Restenosis; Heparin, Low-Molecular-Weight; Humans; Myocar | 2004 |
2 trials available for dalteparin and Coronary Restenosis
| Article | Year |
|---|---|
Spot drug-eluting stenting for long coronary stenoses: long-term results of a randomized clinical study.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary | 2011 |
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Artery Dise | 2001 |
5 other studies available for dalteparin and Coronary Restenosis
| Article | Year |
|---|---|
Does enoxaparin have enough FINESSE to replace unfractionated heparin in primary percutaneous coronary intervention?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Artery Disease; Coronary Restenosis; Enoxap | 2010 |
Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Restenos | 2004 |
Failure of enoxaparin during coronary stenting: a case report.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Corona | 2005 |
The end of systemic anticoagulation therapy for restenosis prevention.
Topics: Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Coronary Artery Disease; Coronary Restenosi | 2001 |
The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Angiography; Coronary Res | 2003 |